Gain Therapeutics, Inc. (GANX)
1.26
-0.03
(-2.33%)
USD |
NASDAQ |
Oct 23, 16:00
1.33
+0.07
(+5.56%)
After-Hours: 20:00
Gain Therapeutics Price : 1.26 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.33 | 1.343 | 1.22 | 1.26 | 645033.0 |
| Oct 22, 2026 | 1.18 | 1.33 | 1.16 | 1.29 | 2.751M |
| Oct 21, 2026 | 1.20 | 1.23 | 1.15 | 1.19 | 609772.0 |
| Oct 20, 2026 | 1.23 | 1.295 | 1.17 | 1.19 | 517005.0 |
| Oct 19, 2026 | 1.26 | 1.290 | 1.21 | 1.25 | 532168.0 |
| Oct 16, 2026 | 1.32 | 1.377 | 1.235 | 1.26 | 467379.0 |
| Oct 15, 2026 | 1.32 | 1.41 | 1.31 | 1.33 | 510815.0 |
| Oct 14, 2026 | 1.37 | 1.42 | 1.295 | 1.32 | 851302.0 |
| Oct 13, 2026 | 1.58 | 1.58 | 1.40 | 1.41 | 799935.0 |
| Oct 12, 2026 | 1.65 | 1.65 | 1.565 | 1.57 | 319798.0 |
| Oct 09, 2026 | 1.61 | 1.66 | 1.610 | 1.64 | 328689.0 |
| Oct 08, 2026 | 1.66 | 1.675 | 1.61 | 1.615 | 361864.0 |
| Oct 07, 2026 | 1.66 | 1.69 | 1.64 | 1.67 | 373931.0 |
| Oct 06, 2026 | 1.70 | 1.75 | 1.655 | 1.67 | 646563.0 |
| Oct 05, 2026 | 1.75 | 1.77 | 1.69 | 1.69 | 351044.0 |
| Oct 02, 2026 | 1.75 | 1.78 | 1.70 | 1.71 | 386094.0 |
| Oct 01, 2026 | 1.725 | 1.773 | 1.67 | 1.72 | 497408.0 |
| Sep 30, 2026 | 1.70 | 1.840 | 1.69 | 1.73 | 787967.0 |
| Sep 29, 2026 | 1.75 | 1.76 | 1.60 | 1.68 | 1.290M |
| Sep 28, 2026 | 1.75 | 1.82 | 1.72 | 1.77 | 548025.0 |
| Sep 25, 2026 | 1.85 | 1.883 | 1.775 | 1.78 | 383023.0 |
| Sep 24, 2026 | 1.84 | 1.855 | 1.79 | 1.84 | 407685.0 |
| Sep 23, 2026 | 1.91 | 1.973 | 1.83 | 1.84 | 292878.0 |
| Sep 22, 2026 | 1.85 | 1.96 | 1.825 | 1.95 | 692700.0 |
| Sep 21, 2026 | 1.80 | 1.85 | 1.780 | 1.84 | 335861.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| Price to Book Value | 4.836 |
| Earnings Yield | -40.16% |
| Market Cap | 54.61M |